首页> 外文学位 >Toward development of an oral, plant-based vaccine against Escherichia coli O157:H7.
【24h】

Toward development of an oral, plant-based vaccine against Escherichia coli O157:H7.

机译:旨在开发针对大肠杆菌O157:H7的口服植物性疫苗。

获取原文
获取原文并翻译 | 示例

摘要

Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is the most common infectious cause of bloody diarrhea in the United States, and a sequela of this infection, the hemolytic uremic syndrome (HUS), is the primary cause of acute renal failure in children in the U.S. The majority of U.S. cases of EHEC O157:H7 have occurred as a consequence of ingestion of undercooked, contaminated hamburger or produce and/or water contaminated with bovine manure. Intimin is the primary adhesin of EHEC O157:H7, and is required for colonization of neonatal calves. I hypothesized that an intimin-based vaccination strategy in calves might reduce colonization of cattle with EHEC O157:H7. To test this concept in a small animal model, I developed transgenic tobacco plant cells that expressed the full length or carboxy-terminal portion (Int261) of EHEC O157:H7 intimin and then immunized mice parenterally with intimin expressed from the plant cells, or fed mice the transgenic plant cells, or both. I was able to show that these mice not only generated an intimin-specific mucosal immune response when primed parenterally and boosted orally but also exhibited a reduced duration of EHEC O157:H7 fecal shedding after challenge. These results suggest that transgenic plants are attractive and feasible production and delivery systems for an intimin-based vaccine for cattle, and such a vaccine can reduce the duration of EHEC O157:H7 shedding in a small animal model. In addition, Shiga toxin type 2 (Stx2) is another important EHEC O157:H7 virulence factor that plays a critical role in the development of potentially fatal HUS in humans. I developed a toxoid of Stx2 by making site-directed changes to the nucleotide sequence of the Stx2 A subunit gene that abrogated cytotoxicity in vitro and in vivo. The Stx2 toxoid elicited toxin-neutralizing antibody when parenterally injected in mice. I also optimized both the Stx2 A toxoid subunit and the B subunit for expression in plants and, thus laid the groundwork for future expression of this Stx2 toxoid molecule in plants.
机译:肠出血性大肠杆菌(EHEC)O157:H7是美国血性腹泻的最常见感染原因,而这种感染的后遗症是溶血性尿毒症综合征(HUS),是该地区儿童急性肾衰竭的主要原因。美国在美国,大多数EHEC O157:H7病例都是由于摄入未煮熟,受污染的汉堡包或受牛粪污染的产品和/或水而发生的。内膜素是EHEC O157:H7的主要粘附素,是新生小牛定植所必需的。我假设牛犊中基于内膜素的疫苗接种策略可能会减少EHEC O157:H7对牛的定殖。为了在小型动物模型中测试此概念,我开发了表达EHEC O157:H7血管紧张素原的全长或羧基末端部分(Int261)的转基因烟草植物细胞,然后使用从植物细胞表达的血管紧张素进行肠胃外免疫或饲喂小鼠转基因植物细胞或两者。我能够证明这些小鼠不仅在肠胃外引发和口服增强时产生内膜特异性粘膜免疫反应,而且在激发后表现出减少的EHEC O157:H7粪便脱落持续时间。这些结果表明,转基因植物是用于牛的基于内膜素的疫苗的有吸引力且可行的生产和递送系统,并且这种疫苗可以减少小动物模型中EHEC O157:H7脱落的持续时间。此外,志贺毒素2型(Stx2)是另一个重要的EHEC O157:H7毒力因子,在人类潜在致命HUS的发生中起关键作用。我对Stx2 A亚基基因的核苷酸序列进行了定点改变,从而开发出Stx2类毒素,从而在体内和体外消除了细胞毒性。当肠胃外注射到小鼠体内时,Stx2类毒素会引发毒素中和抗体。我还优化了Stx2 A类毒素亚基和B亚型在植物中的表达,从而为该Stx2类毒素分子在植物中的未来表达奠定了基础。

著录项

  • 作者

    Judge, Nicole Ann.;

  • 作者单位

    Uniformed Services University of the Health Sciences.;

  • 授予单位 Uniformed Services University of the Health Sciences.;
  • 学科 Biology Microbiology.;Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 178 p.
  • 总页数 178
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号